|
⚲
|
| Keyboard |
| Benevich Eric
✚
|
|
|---|---|
| CIK # | 0001643653 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001643653] | |
| 4 | [0001643653] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Benevich Eric | |
| aTYR Pharma Inc | |
| Neurocrine Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 2,083 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Grant | 6,365 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 1,961 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 1,058 | $124.12 | 131,319 |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2026-02-13 | Grant | 36,287 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Option exercise | 1,961 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Option exercise | 2,083 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 1,124 | $124.12 | 139,511 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Grant | 16,613 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-13 | Tax withheld | 8,963 | $124.12 | 1,112,488 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Option exercise | 2,005 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-02-12 | Tax withheld | 1,082 | $123.10 | 133,194 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-12 | Option exercise | 2,005 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-01-31 | Option exercise | 2,294 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Option exercise | 2,294 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2026-01-31 | Tax withheld | 1,292 | $136.06 | 175,790 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-28 | Sell | 5,970 | $151.74 | 905,888 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-28 | Option exercise | 5,970 | $35.99 | 214,860 |
|
Neurocrine Biosciences Inc NBIX
Incentive Stock Option · derivative
|
2025-11-28 | Option exercise | 5,970 | $0.00 | |
|
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
|
2025-05-01 | Grant | 50,000 | $0.00 | |
| showing 20 of 147 most recent transactions | |||||